
Advancing Clinical Insight, Efficiency, and Access
Diagnostics is moving faster, reaching further, and growing more complex by the day. With growth comes pressure on labs to maintain standards, sustain oversight, and ensure consistent clinical decision‑making as care expands beyond the core lab.
The future of diagnostics won’t be defined by stretching today’s model to meet tomorrow’s demands. It requires partners who offer fresh thinking and forward focused technologies, so labs can confidently grow their business and expand access to care.
Thank you for joining us at ADLM 2026.

Conference Dates: July 25–29, 2027
Location: McCormick Place Convention Center, Chicago, Illinois, USA. (Map)

Clinical excellence starts with more forward-looking insight. With advanced biomarkers and expanding prognostic capabilities, laboratories can help clinicians detect risk earlier, better understand disease progression, and guide care with greater confidence across complex conditions.

Growing complexity demands an integrated, connected approach. Streamlined workflows and connected systems reduce manual steps and variability—helping labs scale volume and complexity with consistency, so teams can focus on higher-value work.

As care extends beyond the central lab, consistent, high-quality diagnostics must extend with it. Flexible sampling and connected informatics help bring testing closer to patients while supporting reliable, standardized results across settings—so labs can support decentralized care and expand reach.

See a list of scientific posters presented by Siemens Healthineers at ADLM 2026 below or visit our Medical Affairs page to see them in detail.
CATEGORY | POSTER TITLE | AUTHORS (presenter's name first) |
Clinical Chemistry | Analytical Performance Evaluation of the Diazo Total Bilirubin Assay on the Atellica CH Analyzer for Use in Neonates | Mark Borgman, Dejan Blagovcanin, Zach Eischeid, Anne Sinopoli, Jennifer Cheek, Nazira Ozgen, Jennifer Snyder. |
Hemostasis | Comprehensive Overview of Preliminary Interference Data for a New D-Dimer Assay | Johanna Droese, Sabine Pilgrim, Matthias Wilkens. |
Infectious Disease | Performance Evaluation of Atellica IM Infectious Disease Assays with Dried Blood Spot Sample | Sai Patibandla, Krishna Singh, Katie Ann Paden. |
Microsampling | Comparison of Capillary Blood to Venous Blood for Use with the Vitamin D Total II Assay on the Atellica IM Analyzer | Agostino Palladino, Brandon Czap, Nancy Camosino, Christopher DiPasquale, Eric G. Olson, Roy Barr, Hattie McKenzie, James W. Jacobson. |
Microsampling | Comparison of Test Results for Several Analytes Using Capillary Blood Versus Venous Blood on the Atellica CH and Atellica IM Analyzers | James Freeman, Jennifer Cheek, Sangita Singh, Christopher DiPasquale, Eric G. Olson, Roy Bar, Hattie McKenzie, James W. Jacobson. |
Microsampling | Quantitative Analysis of Creatinine and HbA1c from Dried Microsamples as a Patient-centered Approach for Value-Based Care Programs | Ramona Seliger, Jens-Peter Brock, Michelle Wittmann, Mathias Karlsson, Johan Olausson, Mikael Ström. |
Reproductive Endocrinology | Short-term Prediction of Severe Preeclampsia Among Women with Hypertensive Disorders of Pregnancy | Sara Love, Agostino Palladino, Andrea Wright, Katie Freeman, Sara Kastrup Shah, JoDell Wilson, Sascha Lange, and Maria Pagano. |
Sepsis | Comprehensive Performance Evaluation of a Rapid, Universal, Sepsis Diagnostic Workflow That Identifies Pathogens and Characterizes Their Antimicrobial Resistance | Ramya VM, Thomas A Hall, Divya S Khandige, Ishita Chakraborty, Lisa Risen, Christine Marzan, Michael Mosel, Jim Hannis, Hila Roshanravan, Robert A. Bonomo, and Megan Carpenter. |
Sepsis | Development of Pre-analytics for a Rapid, Integrated Sepsis Diagnostic Workflow Combining Pathogen Detection with Host Immune Response Profiling | Divya Sharma Khandige, Josh Chenoweth, Ramya VM, Deeksha Hebbar, Chad Porter, Danielle Clark, Thomas A Hall, Lisa Risen, Christine Marzan, Michael Mosel, James Hannis, Hila Roshanravan, and Megan Carpenter. |
Therapeutic Drug Monitoring | Analytical Precision and On-board Stability Evaluation of the EMIT Methotrexate and Amikacin and EMIT 2000 Vancomycin and Digoxin Assays on the Atellica DT 250 Analyzer | Jessica Daughtry, Kenisha Griffin, Jerry Glover, Nicholas Johnson, Benjamin Israel |